Everyday Health: COVID concerns versus Illness Anxiety Disorder
Many people have felt worried about being infected with COVID-19 while going out into public throughout the pandemic, but experts say constant worry or questioning if the slightest of symptoms is COVID may be a sign of illness anxiety disorder (IAD).
Shana Feibel, DO, assistant professor of clinical psychiatry & behavioral neuroscience in the University of Cincinnati College of Medicine and a psychiatrist at the Lindner Center of Hope in Mason, told Everyday Health that people with "normal" concerns will follow general public health recommendations like getting vaccinated, wearing masks and washing hands often. It's also a typical response to stay up to date on the latest guidance from experts like the Centers for Disease Control and Prevention.
However, a person may have IAD if they are often worrying about infection despite no noticeable symptoms.
“The general concern about an illness often far outweighs the chances of a serious illness,” Feibel said.
Read the Everyday Health article.
Featured photo courtesy of Unsplash.
Related Stories
Pocket-sized population threat
June 10, 2026
The Financial Times took a deep dive into why populations around the world continue to be on the decline. The publication cited new University of Cincinnati research as part of the investigation that looks at the fall of fertility in the digital era.
Patients with developmental disabilities may benefit with an integrated care model
June 9, 2026
Researchers from the University of Cincinnati and Ohio State University have found that adults with developmental disabilities who have integrated care were less likely to go to the emergency room or be hospitalized than others who were not. Their work was published in Disability and Health Journal.
UC physician-researcher's work yields landmark five-year data for Crohn's disease drug
June 8, 2026
The University of Cincinnati College of Medicine’s Anita Afzali, MD, leads a landmark study revealing five-year efficacy and safety data for a Crohn’s disease drug called guselkumab.